» Articles » PMID: 22433822

Dynamic Contrast-enhanced Imaging Techniques: CT and MRI

Overview
Journal Br J Radiol
Specialty Radiology
Date 2012 Mar 22
PMID 22433822
Citations 84
Authors
Affiliations
Soon will be listed here.
Abstract

Over the last few decades there has been considerable research into quantifying the cerebral microvasculature with imaging, for use in studies of the human brain and various pathologies including cerebral tumours. This review highlights key issues in dynamic contrast-enhanced CT, dynamic contrast-enhanced MRI and arterial spin labelling, the various applications of which are considered elsewhere in this special issue of the British Journal of Radiology.

Citing Articles

Translation of dynamic contrast-enhanced imaging onto a magnetic resonance-guided linear accelerator in patients with head and neck cancer.

Dubec M, Berks M, Price J, McDaid L, Gaffney J, Little R Phys Imaging Radiat Oncol. 2025; 33():100689.

PMID: 39802650 PMC: 11721217. DOI: 10.1016/j.phro.2024.100689.


Performance evaluation of a 4D similarity filter for dynamic CT angiography imaging of the liver.

Tunissen S, Smit E, Mikerov M, Prokop M, Sechopoulos I Med Phys. 2024; 51(12):8814-8827.

PMID: 39264288 PMC: 11656287. DOI: 10.1002/mp.17394.


Review of tracer kinetic models in evaluation of gliomas using dynamic contrast-enhanced imaging.

Zhou J, Hou Z, Tian C, Zhu Z, Ye M, Chen S Front Oncol. 2024; 14:1380793.

PMID: 38947892 PMC: 11211364. DOI: 10.3389/fonc.2024.1380793.


Predicting cytogenetic risk in multiple myeloma using conventional whole-body MRI, spinal dynamic contrast-enhanced MRI, and spinal diffusion-weighted imaging.

Den Berghe T, Verberckmoes B, Kint N, Wallaert S, De Vos N, Algoet C Insights Imaging. 2024; 15(1):106.

PMID: 38597979 PMC: 11006637. DOI: 10.1186/s13244-024-01672-1.


Standardized brain tumor imaging protocols for clinical trials: current recommendations and tips for integration.

Sanvito F, Kaufmann T, Cloughesy T, Wen P, Ellingson B Front Radiol. 2023; 3:1267615.

PMID: 38152383 PMC: 10751345. DOI: 10.3389/fradi.2023.1267615.


References
1.
Calamante F, Thomas D, Pell G, Wiersma J, Turner R . Measuring cerebral blood flow using magnetic resonance imaging techniques. J Cereb Blood Flow Metab. 1999; 19(7):701-35. DOI: 10.1097/00004647-199907000-00001. View

2.
Detre J, Leigh J, Williams D, Koretsky A . Perfusion imaging. Magn Reson Med. 1992; 23(1):37-45. DOI: 10.1002/mrm.1910230106. View

3.
Batchelor T, Duda D, Tomaso E, Ancukiewicz M, Plotkin S, Gerstner E . Phase II study of cediranib, an oral pan-vascular endothelial growth factor receptor tyrosine kinase inhibitor, in patients with recurrent glioblastoma. J Clin Oncol. 2010; 28(17):2817-23. PMC: 2903316. DOI: 10.1200/JCO.2009.26.3988. View

4.
Alsop D, Detre J . Reduced transit-time sensitivity in noninvasive magnetic resonance imaging of human cerebral blood flow. J Cereb Blood Flow Metab. 1996; 16(6):1236-49. DOI: 10.1097/00004647-199611000-00019. View

5.
Parkes L, Tofts P . Improved accuracy of human cerebral blood perfusion measurements using arterial spin labeling: accounting for capillary water permeability. Magn Reson Med. 2002; 48(1):27-41. DOI: 10.1002/mrm.10180. View